Skip to main content
SAMJIN PHARMACEUTICAL CO.,LTD logo

SAMJIN PHARMACEUTICAL CO.,LTD — Investor Relations & Filings

Ticker · 005500 ISIN · KR7005500004 KO Manufacturing
Open in API
Filings indexed 253 across all filing types
Latest filing 2023-05-15 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 005500

About SAMJIN PHARMACEUTICAL CO.,LTD

https://www.samjinpharm.co.kr/

Samjin Pharmaceutical Co., Ltd. is a pharmaceutical company engaged in the research, development, manufacturing, and sale of medicines. The company's portfolio includes a wide range of over-the-counter (OTC) and prescription drugs, offered in various formulations such as oral, drop, and injectable forms. Notable products include the analgesic Gevorin, the antiplatelet agent Plavix, and the hypercholesterolemia treatment Newstatin-R. A central part of its strategy is a strong commitment to R&D, focusing on creating innovative new drugs to address diseases with high unmet medical needs. The company actively develops novel therapeutics for severe conditions, including cardiovascular, respiratory, and gastrointestinal diseases, with the goal of becoming a global pharmaceutical innovator.

Recent filings

Filing Released Lang Actions
분기보고서 (2023.03)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for Samjin Pharmaceutical Co., Ltd. for the first quarter of 2023 (January 1, 2023, to March 31, 2023). It contains comprehensive financial statements, management discussion, and operational details, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2023
2023-05-15 Korean
[기재정정]사업보고서 (2022.12)
Annual Report Classification · 100% confidence The document is a 'Business Report' (사업보고서) for Samjin Pharmaceutical Co., Ltd. for the 55th fiscal year (2022). It contains comprehensive financial statements, management discussion and analysis, governance information, and operational details. It is a formal annual filing submitted to the Financial Supervisory Service (FSS) and the Korea Exchange (KRX). In the context of the provided categories, this corresponds to the 10-K (Annual Report). FY 2022
2023-04-10 Korean
주요사항보고서(자기주식취득신탁계약체결결정)
Transaction in Own Shares Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) filed with the Korean Financial Supervisory Service/Korea Exchange regarding the decision to enter into a trust agreement for the acquisition of treasury shares (자기주식취득 신탁계약 체결 결정). This is a corporate action related to share buybacks, which falls under the category of 'Transaction in Own Shares'.
2023-03-24 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official announcement titled '정기주주총회결과' (Annual General Meeting Results) for Samjin Pharmaceutical. It details the outcomes of the meeting, including financial statement approval, dividend declarations, board member appointments, and amendments to business purposes. This falls directly under the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2023-03-24 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 100% confidence The document is a formal regulatory filing submitted to the Financial Services Commission/Korea Exchange regarding the appointment of an outside director (사외이사). This falls under the category of changes in the board of directors or senior management.
2023-03-24 Korean
[기재정정]벌금등의부과
Legal Proceedings Report Classification · 100% confidence The document is a regulatory filing (specifically a 'Correction Report' or 'Amendment') regarding a previous disclosure about a tax penalty/fine imposed on the company. It details the adjustment of the penalty amount following a tax appeal process and outlines future legal actions (administrative litigation). Since this relates to a regulatory disclosure of a legal/tax matter and does not fit into specific categories like 10-K or IR, it is classified as a Regulatory Filing (RNS).
2023-03-24 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.